The 12 Hallmarks of Aging in Dogs, Explained
Read full insightNatural Alternatives to Longevity Drugs for Cats
Why no supplement copies rapamycin, Felycin-CA1 or LOY-002, what helps cats live longer, and how to judge the supplements people ask about.
As Seen On
Contents
Natural alternatives for cats at a glance
- Natural alternative to rapamycin or Felycin-CA1?
- None shown in cats; Felycin-CA1 is rapamycin itself
- Natural LOY-002 for cats?
- No; LOY-002 is a dog drug, and it isn't approved
- Best-supported habit
- Vet visits at least every six months from age 10
- Most useful early check
- Kidney screening: it found disease in 8% of healthy-looking older cats
- Weight
- Cats just above ideal had the lowest death risk in a 2,609-cat study
- Supplement with the most cat data
- Omega-3s, for joint stiffness in a 16-cat trial
- NAD+ supplements
- No published trial in cats found
- Never give cats
- Alpha-lipoic acid or concentrated essential oils
Each cat longevity drug and its closest natural idea
| Drug and its target | Closest "natural" idea | Evidence in cats |
|---|---|---|
| Felycin-CA1 (rapamycin): heart-wall thickening in early HCM | "Natural rapamycin" or mTOR supplements | No cat studies found; rapamycin itself was tested in 43 cats for heart-wall thickness, not lifespan |
| LOY-002: aging metabolism, in senior dogs only | Keeping a healthy weight | In 2,609 cats, the lowest death risk was at a body condition score of 6 of 9 |
| PURR-001: age-related muscle loss | Muscle checks at every vet visit | No supplement shown to rebuild muscle in older cats; guidelines call for muscle scoring at each exam |
| FeliAIM: chronic kidney disease | Foods branded "for AIM" | No trial shows a food copies the injected protein; renal diets are linked to longer survival |
| OKV-119 (exenatide implant): obesity | A vet weight plan | 97% of 413 overweight cats lost weight on a diet plan |
Competitor label and pricing facts checked November 11, 2026. Sources are listed in the References section below.
Sources and further detail
- Loyal, *For veterinarians* (checked November 2026)
- FDA (14 March 2025). *FDA conditionally approves drug for management of ventricular hypertrophy in cats*
- FDA, *Conditional approval explained: a resource for veterinarians*
- Kaplan JL, Rivas VN, Walker AL et al. *JAVMA* (2023). Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial
- The Underbite (18 Aug 2026). *First feline sarcopenia drug trial posts results*
- IAM CAT (24 April 2026). *Notice of manufacturing and marketing approval application for the AIM cat drug FeliAIM* (in Japanese)
- Inaba Petfood, *for AIM pet food series* (in Japanese, checked November 2026)
- Teng KT, McGreevy PD, Toribio JL et al. *Journal of Feline Medicine and Surgery* (2018). Strong associations of nine-point body condition scoring with survival and lifespan in cats
- Flanagan J, Bissot T, Hours MA et al. *PLoS One* (2018). An international multi-center cohort study of weight loss in overweight cats: differences in outcome in different geographical locations
- Cline MG, Burns KM, Coe JB et al. *Journal of the American Animal Hospital Association* (2021). 2021 AAHA nutrition and weight management guidelines for dogs and cats
- Plantinga EA, Everts H, Kastelein AM, Beynen AC. *Veterinary Record* (2005). Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets
- American Association of Feline Practitioners (2021). *AAFP releases updated feline senior care guidelines*
- Taylor S, Finch N, Caney S et al. *Journal of Feline Medicine and Surgery* (2026). 2026 iCatCare consensus guidelines on the diagnosis and management of chronic kidney disease in cats
- Montoya M, Morrison JA, Arrignon F et al. *Frontiers in Veterinary Science* (2023). Life expectancy tables for dogs and cats derived from clinical data
- Cornell Feline Health Center, *Feline diabetes*
- Cornell Feline Health Center, *Obesity*
- Pye CR, Dowgray NJ, Eyre K et al. *Frontiers in Veterinary Science* (2026). Patterns of morbidity, multimorbidity, and mortality in aging cats: findings from seven years of the Cat Prospective Aging and Welfare Study
- Bellows J, Berg ML, Dennis S et al. *Journal of the American Animal Hospital Association* (2019). 2019 AAHA dental care guidelines for dogs and cats
- Taylor AR, McDonald J, Foreman-Worsley R et al. *Journal of Feline Medicine and Surgery* (2025). Mortality and life table analysis in a young cohort of pet cats in the UK
- Corbee RJ, Barnier MM, van de Lest CH, Hazewinkel HA. *Journal of Animal Physiology and Animal Nutrition* (2013). The effect of dietary long-chain omega-3 fatty acid supplementation on owner's perception of behavior and locomotion in cats with naturally occurring osteoarthritis
- Magalhães TR, Lourenço AL, Gregório H, Queiroga FL. *In Vivo* (2021). Therapeutic effect of EPA/DHA supplementation in neoplastic and non-neoplastic companion animal diseases: a systematic review
- Nestlé Purina PetCare, *Effect of nutritional interventions on longevity in senior cats* (research report on Cupp et al.)
- Rishniw M, Wynn SG. *Journal of Feline Medicine and Surgery* (2011). Azodyl, a synbiotic, fails to alter azotemia in cats with chronic kidney disease when sprinkled onto food
- Ryave J, Coleman A. *Journal of Veterinary Science* (2025). Rapamycin as a potential intervention to promote longevity and extend healthspan in companion dogs
- FDA, *FDA's regulation of pet food*
- Boehringer Ingelheim (14 Aug 2023). *Senvelgo receives FDA approval*
- Hill AS, Werner JA, Rogers QR et al. *Journal of Animal Physiology and Animal Nutrition* (2004). Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats
- Pet Poison Helpline, *Essential oils and cats*











